Effect of loxapine on electrical brain activity, intracranial pressure, and middle cerebral artery flow velocity in traumatic brain-injured patients

Neurocritical Care

Volumn 7, Issue 2, 2007, Pages 124-127

  Lescot, Thomas ^a   Pereira, Ana Rosa ^a   Abdennour, Lamine ^a   Sanchez Pena, Paola ^a   Naccache, Lionel ^a   Coriat, Pierre ^a   Puybasset, Louis ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Agitation; Antipsychotics; Continuous electroencephalogram monitoring; Delirium; Intracranial pressure; Loxapine; Traumatic brain injury

Indexed keywords

LOXAPINE; MIDAZOLAM; SUFENTANIL;

ADOLESCENT; ADULT; ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; FLOW RATE; HUMAN; INTRACRANIAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BLOOD FLOW VELOCITY; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTRACRANIAL PRESSURE; LOXAPINE; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MONITORING, PHYSIOLOGIC; TREATMENT OUTCOME;

EID: 36949028729     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-0051-7     Document Type: Article

References (14)

1. Flacker JM, Lipsitz LA. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 1999;54:B239-46.
2. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr., Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. Jama 2004;291:1753-62.
3. Lombard LA, Zafonte RD. Agitation after traumatic brain injury: considerations and treatment options. Am J Phys Med Rehabil 2005;84:797-812.
4. Elovic EP, Lansang R, Li Y, Ricker JH. The use of atypical antipsychotics in traumatic brain injury. J Head Trauma Rehabil 2003;18:177-95.
5. Krieger D, Hansen K, McDermott C, Matthews R, Mitchell R, Bollegala N, Bhalerao S. Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury. Neuro-Rehabil 2003;18:205-8.
6. Fenton M, Murphy B, Wood J, Bagnall A, Chue P, Leitner M. Loxapine for schizophrenia. Cochrane Database Syst Rev 2000:CD001943.
7. Rosati DL. Early polyneuropharmacologic intervention in brain injury agitation. Am J Phys Med Rehabil 2002;81:90-3.
8. Lescot T, Bonnet MP, Zouaoui A, Muller JC, Fetita C, Coriat P, Puybasset L. A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma. Intensive Care Med 2005;31:1042-50.
9. Centorrino F, Price BH, Tuttle M, Bahk WM, Hennen J, Albert MJ, Baldessarini RJ. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002;159:109-15.
10. Yamada K, Isotani T, Irisawa S, Yoshimura M, Tajika A, Yagyu T, Saito A, Kinoshita T. EEG global field power spectrum changes after a single dose of atypical antipsychotics in healthy volunteers. Brain Topogr 2004;16:281-5.
11. Nakayama M, Kanaya N, Ichinose H, Yamamoto S, Namiki A. Intravenous droperidol causes a reduction in the bispectral index in propofol-sedated patients during spinal anesthesia. Anesth Analg 2003;96:765-8.
12. Barthel JS, Marshall JB, King PD, Afridi SA, Gibb LG, Madsen R. The effect of droperidol on objective markers of patient cooperation and vital signs during esophagogastroduodenoscopy: a randomized, double-blind, placebo-controlled, prospective investigation. Gastrointest Endosc 1995;42:45-50.
13. Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 1998;155:921-8.
14. Milbrandt EB, Kersten A, Kong L, Weissfeld LA, Clermont G, Fink MP, Angus DC. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005;33:226-9 discussion 263-5.